In this clinical trial the effect of the implant-abutment morphology (platform-switched vs platform matched) will be assessed in both soft tissue (soft tissue thickness) and hard tissue (marginal bone loss) outcomes. Several clinical predictors (initial implant position level, gingival biotype, abutment height and prosthetic emergence profile) will also be taken into account as modulating factors of the clinical outcome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in the Peri-implant Marginal Bone level
Timeframe: At baseline (reference), in comparison with 3, 6 and 12 months
Change in the Implant stablity quotient
Timeframe: At baseline (reference), and in comparison with the 3 months follow-up
Change in the Gingival Thickness
Timeframe: At baseline (reference) and in comparison with the 3, 6 and 12 months follow-up